BioGaia
105.20 SEK
-3.49 %
Less than 1K followers
BIOG B
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
-3.49 %
-6.49 %
-0.94 %
+5.20 %
+11.68 %
-17.88 %
+3.44 %
+17.28 %
+1,381.00 %
BioGaia is a biotechnology company operating in the pharmaceutical industry and focuses on the development, manufacturing and distribution of probiotics for health and well-being. The company's products are aimed at individuals and healthcare institutions. The business is global with a primary presence in Europe, North America and Asia. BioGaia was founded in 1990 and is headquartered in Stockholm.
Read moreMarket cap
10.64B SEK
Turnover
45.86M SEK
Revenue
1.42B
EBIT %
29.76 %
P/E
30.23
Dividend yield-%
6.56 %
Revenue and EBIT-%
Revenue B
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
12.2
2026
Annual report '25
7.5
2026
General meeting '26
7.5
2026
Interim report Q1'26
All
Webcasts
Press releases
ShowingAll content types
BioGaia, Audiocast, Q4'25
BioGaia, Audiocast, Q3'25
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
